E. Doug Grindstaff II has held several Senior Executive and Board positions in the Bio Tech and High Tech industries prior to his role with the CMMI Institute, including CEO of NuSirt Sciences, CEO-in-Residence for Carnegie Innovations Portfolio, and President of the Invisible Fence brand.
Doug additionally served as Chairman and President of Bioganic Biopesticide, where he oversaw rapid expansion into the retail marketplace, as well as the acquisition of the organization by a well-known consumer brands company.
Doug’s executive experience also includes private and public consumer brand companies, namely Kraft Foods, Inc.
Track: CMMI Adoption: Healthcare Sector
Presentation Title: Improving Patient Safety Through Continuous Improvement
Presentation Summary: The CMMI Institute spent the last 18 months working with the FDA, MDIC and Medical Device Industry to use the CMMI to drive continuous improvement and improve patient outcomes. The FDA is supporting enrollment for select companies by eliminating the need for 30 Notifications for manufacturing changes. The program will be piloted in 2018 and 2019. This concept of shifting accountability from regulators to industry has potential application in a wide range of regulated industries.